a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with SVRA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then SVRA could also see price increases.
Ticker / NAME | Correlation To ORIC | 1D Price Change % | ||
---|---|---|---|---|
ORIC | 100% | -2.89% | ||
SVRA - ORIC | 42% Loosely correlated | -1.41% | ||
ACLX - ORIC | 41% Loosely correlated | -3.81% | ||
KYMR - ORIC | 40% Loosely correlated | -4.22% | ||
DAWN - ORIC | 39% Loosely correlated | -2.46% | ||
ABCL - ORIC | 38% Loosely correlated | -2.34% | ||
More |
Ticker / NAME | Correlation To ORIC | 1D Price Change % |
---|---|---|
ORIC | 100% | -2.89% |
tumor theme (2 stocks) | 100% Closely correlated | +0.95% |
therapeutic theme (4 stocks) | 48% Loosely correlated | +1.08% |
cancer theme (87 stocks) | 44% Loosely correlated | +0.89% |
pharmaceuticals theme (167 stocks) | 41% Loosely correlated | +0.82% |
oncology theme (18 stocks) | 38% Loosely correlated | +0.37% |